University of Wisconsin–Madison
Wisconsin Head & Neck Cancer SPORE annual retreat 2018

The Wisconsin Head & Neck Cancer SPORE team seeks to identify and translate new scientific discoveries into significant and durable treatment advances for patients with Head & Neck Cancer.

Welcome to the Wisconsin Head & Neck Cancer Specialized Program of Research Excellence!

The University of Wisconsin Department of Human Oncology and the UW Carbone Cancer Center, under the direction of Principal Investigator Paul Harari, were awarded Wisconsin’s first NIH-funded Specialized Program of Research Excellence (SPORE) in August 2016.

The Wisconsin SPORE focuses on Head and Neck Cancer translational research, which means that the goals of each SPORE research project must link laboratory research (bench) to the clinic setting (bedside) and ultimately aim to improve overall outcome for patients with Head and Neck Cancer. The Wisconsin Head and Neck SPORE comprises four main translational research projects, three supporting cores and two pilot funding programs.

Funding Announcements

The NCI has issued four new RFAs for FY19 as part of the Immuno-Oncology Translational Network that might be of interest to the SPORE community. Two are in immunoprevention, one is in immune-engineering, and the final RFA is a reissuance of the immunotherapy (non-pediatric) funding opportunity announcement that has been previously awarded.

RFA-CA-19-012: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3 Clinical Trials Not Allowed)

RFA-CA-19-013: Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed)

RFA-CA-19-014: Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed)

RFA-CA-19-015: Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)

 

Funding opportunities for HNSCC research supported by NIDCR

PAR-18-530 “Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment” R01

PAR-18-009 “Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems R01

PA-17-459 “Biology of Lung, and Head and Neck Preneoplasias” R01

PA-17-460 “Biology of Lung, and Head and Neck Preneoplasias” R21

PA-17-239 “Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes” R01

PA-17-243 “Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes” R21